NaiVec Completes Second Supply of New Drug Development Candidates to Global Pharmaceutical Companies
[Asia Economy Reporter Hyunseok Yoo] Naivek announced on the 19th that it has completed the secondary supply of five types of cardiovascular therapeutic proteins, which are preclinical candidate substances, to a global pharmaceutical company. This supply confirms the final optimization stage and is expected to proceed to actual mass production research after verification.
Since January, Naivek has signed a production and supply contract for protein therapeutics with one of the world's top three global pharmaceutical companies and has been supplying protein therapeutics based on vector design and purification technology through thorough prior verification.
The new drug development candidates currently being supplied correspond to the preclinical stage. Accordingly, Naivek plans to supply therapeutic proteins long-term depending on the progress of new drug development research by the global pharmaceutical company. Due to the nature of new drug development, once clinical trials are actively underway, requests for increased supply volume are inevitable, and preparations to respond to this are also underway.
A Naivek official stated, “The production and supply of protein therapeutics for new drug development are proceeding smoothly according to each stage,” adding, “As the client’s heart disease research accelerates, large-scale supply volume requests are expected with the progress of clinical trials.”
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military Spokesperson: "Ceasefire Was an Opportunity to Strengthen Forces... Ready to Respond to War"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Naivek’s peptide drug delivery platform, 'NIPEP-TPP,' is a drug delivery system that maximizes the efficacy of therapeutic drugs and minimizes side effects by providing ‘targeting’ functionality that allows the therapeutic agent to act precisely at the intended site, as well as cell and tissue penetration capabilities. Based on this platform, Naivek plans to accelerate growth focusing on peptide-based new drug pipelines and protein therapeutic businesses.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
